Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer

NCT01186484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: JNJ-212082

Sponsor

Janssen Pharmaceutical K.K.